BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33542786)

  • 1. 1-O-Hexyl-2,3,5-Trimethylhydroquinone Ameliorates the Development of Preeclampsia through Suppression of Oxidative Stress and Endothelial Cell Apoptosis.
    Jiang L; Gong Y; Rao J; Yang Q; Gao N; Li G; Ma Y
    Oxid Med Cell Longev; 2021; 2021():8839394. PubMed ID: 33542786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of 1-O-hexyl-2,3,5-trimethylhydroquinone on ischaemia/reperfusion-induced neuronal injury by activating the Nrf2/HO-1 pathway.
    Tang C; Hu Y; Lyu H; Gao J; Jiang J; Qin X; Wu Y; Wang J; Chai X
    J Cell Mol Med; 2020 Sep; 24(18):10468-10477. PubMed ID: 32677362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
    Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
    Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTHQ (1-O-hexyl-2,3,5-trimethylhydroquinone), an anti-lipid-peroxidative compound: its chemical and biochemical characterizations.
    Hino T; Kawanishi S; Yasui H; Oka S; Sakurai H
    Biochim Biophys Acta; 1998 Sep; 1425(1):47-60. PubMed ID: 9813237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol mitigates trophoblast and endothelial dysfunction partly via activation of nuclear factor erythroid 2-related factor-2.
    Gurusinghe S; Cox AG; Rahman R; Chan ST; Muljadi R; Singh H; Leaw B; Mockler JC; Marshall SA; Murthi P; Lim R; Wallace EM
    Placenta; 2017 Dec; 60():74-85. PubMed ID: 29208243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-
    Park HJ; Kang JK; Lee MK
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30823626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadd45α as an upstream signaling molecule of p38 MAPK triggers oxidative stress-induced sFlt-1 and sEng upregulation in preeclampsia.
    Luo X; Yao ZW; Qi HB; Liu DD; Chen GQ; Huang S; Li QS
    Cell Tissue Res; 2011 Jun; 344(3):551-65. PubMed ID: 21519896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong anti-mutagenic activity of the novel lipophilic antioxidant 1-O-hexyl-2,3,5-trimethylhydroquinone against heterocyclic amine-induced mutagenesis in the Ames assay and its effect on metabolic activation of 2-amino-6-methyldipyrido[1,2-a:3',2'-d] imidazole (Glu-p-1).
    Hirose M; Iwata S; Ito E; Nihro Y; Takahashi S; Mizoguchi Y; Miki T; Satoh T; Ito N; Shirai T
    Carcinogenesis; 1995 Sep; 16(9):2227-32. PubMed ID: 7554080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia.
    Onda K; Tong S; Nakahara A; Kondo M; Monchusho H; Hirano T; Kaitu'u-Lino T; Beard S; Binder N; Tuohey L; Brownfoot F; Hannan NJ
    Hypertension; 2015 Apr; 65(4):855-62. PubMed ID: 25667213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia.
    Rahman RA; Murthi P; Singh H; Gurungsinghe S; Leaw B; Mockler JC; Lim R; Wallace EM
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulforaphane improves endothelial function and reduces placental oxidative stress in vitro.
    Cox AG; Gurusinghe S; Abd Rahman R; Leaw B; Chan ST; Mockler JC; Murthi P; Marshall SA; Lim R; Wallace EM
    Pregnancy Hypertens; 2019 Apr; 16():1-10. PubMed ID: 31056142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome.
    Hastie R; Ye L; Hannan NJ; Brownfoot FC; Cannon P; Nguyen V; Tong S; Kaitu'u-Lino TJ
    Pregnancy Hypertens; 2018 Oct; 14():125-130. PubMed ID: 30527099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV ameliorates preeclampsia-induced oxidative stress through the Nrf2/HO-1 pathway in a rat model.
    Yang S; Zhang R; Xing B; Zhou L; Zhang P; Song L
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E904-E911. PubMed ID: 32924527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes From Women With Preeclampsia Induced Vascular Dysfunction by Delivering sFlt (Soluble Fms-Like Tyrosine Kinase)-1 and sEng (Soluble Endoglin) to Endothelial Cells.
    Chang X; Yao J; He Q; Liu M; Duan T; Wang K
    Hypertension; 2018 Dec; 72(6):1381-1390. PubMed ID: 30571229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia.
    Hannan NJ; Binder NK; Beard S; Nguyen TV; Kaitu'u-Lino TJ; Tong S
    PLoS One; 2018; 13(4):e0187082. PubMed ID: 29641523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paeoniflorin alleviates endothelial dysfunction caused by overexpression of soluble fms-like tyrosine kinase 1 and soluble endoglin in preeclampsia via VEGFA upregulation.
    Zhang J; Hua W; Zhao X; Yang F; Guo T; Zhang J; Zheng X; Liang W
    Biosci Biotechnol Biochem; 2021 Mar; 85(4):814-823. PubMed ID: 33590855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
    Cheng M; He P; Fu J
    J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.